Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
January 07 2009 - 3:00PM
PR Newswire (US)
THOUSAND OAKS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Amgen
(NASDAQ: AMGN) will present at the 27th Annual JP Morgan Global
Healthcare Conference at 9:00 a.m. Pacific Time on Monday, Jan. 12,
2009, at the Westin St. Francis in San Francisco, Calif. Amgen
Chairman and CEO Kevin Sharer will present at the conference. Live
audio of the presentation will be available over the Internet and
can be accessed from Amgen's Web site, http://www.amgen.com/, under
Investors. (Logo:
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO) Information
regarding presentation time, webcast availability, and webcast
links are available on Amgen's Investor Relations Events Calendar.
About Amgen Amgen discovers, develops, manufactures and delivers
innovative human therapeutics. A biotechnology pioneer since 1980,
Amgen was one of the first companies to realize the new science's
promise by bringing safe and effective medicines from lab, to
manufacturing plant, to patient. Amgen therapeutics have changed
the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid
arthritis, and other serious illnesses. With a deep and broad
pipeline of potential new medicines, Amgen remains committed to
advancing science to dramatically improve people's lives. To learn
more about our pioneering science and our vital medicines, visit
http://www.amgen.com/. CONTACT: Amgen, Thousand Oaks David Polk,
805-447-4613 or 805-490-0661 (media) Arvind Sood, 805-447-1060
(investors) http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO
http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: media, David
Polk, +1-805-447-4613, or +1-805-490-0661, or investors, Arvind
Sood, +1-805-447-1060, both of Amgen, Thousand Oaks Web Site:
http://www.amgen.com/
Copyright